Sudair Pharmaceuticals Company announced that it will receive SAR 173 million in a round of funding on January 8, 2024. The transaction includes the participation from returning investor, Al Hammadi Holding Company. The transaction has been approved by the shareholder board.

The company has issued equity in the transaction.